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Abstract 
Traditional steady state aerobic exercise training is a proven method to treat 
metabolic disorders, in particular diabetes. Short duration high intensity interval training 
(HIIT) induces similar metabolic adaptations and improvements in aerobic performance. 
To date, most HIIT studies have utilized “all out” efforts. Lower intensity HIIT has 
recently been demonstrated to produce similar effects to all out efforts, however, it is 
unknown whether a lower intensity HIIT has the capacity to improve glucose handling in 
a diseased population. Nine untrained type 2 diabetics [age=22 ± 9.1 yr; BMI = 33.9 ± 
5.31 (mean ± SD); VO2max = 1.95L/min± .21] performed 6 training sessions of HIIT over 
2 weeks. Anthropometric measures, fasting glucose, fasting insulin, glucose tolerance, 
fasting triglycerides, and cholesterol were unchanged with training, but there was a 
significant reduction in blood glucose after each interval bout (p<0.05). This provides 
novel and important pilot data for future studies.   
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Chapter 1. Literature Review 
Diabetes and the associated risk factors of obesity, hypertension, impaired blood 
lipids and elevated cholesterol (all together known as the metabolic syndrome) have 
reached global epidemic proportions, making these metabolic disturbances, and diabetes 
in particular, extremely costly (2.5-15% of health budgets) (1). The increase in diabetes 
diagnoses have already exceeded the 65% Canadian increase that was predicted to occur 
within 35 years from 1995 to 2030 (102).  In fact, the prevalence of diabetes mellitus 
(DM) is expected to rise from 171 million cases worldwide in 2000 to 366 million cases 
in 2030 (1) with Type II or Adult Onset Diabetes (T2D) accounting for 90-95% of all 
diabetic cases (3).  Unlike Type I diabetes (T1D), in T2D, both insulin resistance and 
impaired insulin secretion contribute to improper glucose handling. Notably, this type is 
considered preventable. Two primary modifiable risk factors for T2D are obesity and a 
lack of physical activity (2; 106) which also happen to be risk factors for the number one 
killer of Canadians, cardiovascular disease (CVD) (6). This makes the study of 
interventions to prevent or limit the progression of diabetes of grave importance.  
1.1 T2D and Insulin Resistance 
 
T2D is the most common form of DM and was commonly referred to as insulin 
independent or adult onset diabetes.  The latter name has had to be modified since the 
occurrence of this disease is becoming more and more prevalent in the young North 
American population, specifically in females and those less than 50 years of age (47). As 
mentioned above, 2 correlates with this increase are a rise in obesity unaccompanied by a 
sedentary lifestyle and physical inactivity. Moreover, cardiovascular mortality, which is 
also associated with these factors, is 2-4 times greater in those with T2D than non-
diabetics (105). 
DM is a term from the Greek meaning “like a siphon” (diabetes) and “sweet” 
(mellitus).  These terms indicate the two main characteristics of this disorder, excessive 
urination (polyuria) and increased blood sugar (glucose) that is evident in the urine 
(glucosuria) (26). Aretaeus of Cappodocia, a Greek physician, was the first to give a 
medical description of the disorder, stating that it is ‘like the melting down of flesh and 
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limbs into urine’ because in an untreated state, the body is unable to store or provide 
energy for normal physiology and the excess blood glucose that has to be secreted 
requires copious amounts of water (6). Untreated diabetics, especially T1D, usually 
notice a reduction in body weight and energy as the first signs of this disease.  
Interestingly, it was not until 1797 that Scottish physician John Rollo created the first 
medical therapy to treat diabetes through nutrition of an animal diet high in fat and 
protein, and it was not until the 1900’s that starvation and exercise became common 
methods of treating diabetics, both of which are still recommended today in some form.  
Currently, DM is diagnosed on the basis of World Health Organization (WHO) 
recommendations from 1999, incorporating both fasting and a 2h post-glucose load (75 
g) criteria into a diagnostic classification that can be used by clinicians and the general 
public (See Table 1) (3).   
In order to further understand the underlying mechanisms behind the pathogenesis 
of T2D, it is necessary to first examine how normal blood glucose levels are maintained. 
Insulin is one of the most potent and anabolic hormones in the body and it plays a critical 
role in blood glucose homeostasis. After consuming a meal, insulin is released by the 
beta-cells (β-cell) of the pancreatic Islets of Langerhans in anticipation of and in response 
to increased levels of circulating glucose and to a lesser extent other substrates (protein 
and fats). The primary role of insulin in this regard is the storage of metabolic substrates, 
however, its release into the circulation predominantly results in an increase in glucose 
transport, metabolism and storage by muscle and adipose tissue. Moreover, insulin 
secretion inhibits glucagon secretion (i.e. its counter regulatory hormone that responds to 
and attempts to correct low blood glucose) and decreases lipolysis (i.e. fat 
metabolism)(76). 
Insulin action is initiated by insulin binding to the alpha (α) subunit of its cell-
surface insulin receptor (IR) (Figure 1.1 A).The IR is a transmembrane enzymatic 
(tyrosine kinase) receptor and insulin binding leads to autophosphorylation of the IR 
through the beta (β)-subunits thereby allowing activation of the intracellular tyrosine 
kinase portion of the receptor.  This then phosphorylates other proteins eventually 
enabling downstream signaling (Figure 1.1 B)(69; 95). Several steps later, including the 
generation of phosphatidylinositol 3, 4, 5 triphosphate (PIP3), a protein named AkT is 
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activated (Figure 1.1 C). This protein molecule is central to the increase in cellular 
glucose uptake through the translocation of glucose transporters (GLUT-4) to the plasma 
membrane (Figure 1.1 D). Therefore, in response to insulin, GLUT-4, which is expressed 
in insulin sensitive cells such as muscle and adipose tissue, moves to the membrane to 
facilitate glucose uptake and help maintain blood glucose homeostasis.  Further, insulin 
signaling increases glycogen and fatty acid synthesis, thereby causing the storage of 
available glucose and substrates (86). Insulin resistance, which is a hallmark of T2D, is 
caused by a disruption in the above signaling pathway and is a common underlying 
condition associated with both obesity and T2D (95). Insulin resistance is when a normal 
amount of insulin produces a below normal biological response (95) and is typically a 
problem at the level of the insulin sensitive tissue(s). Insulin resistance shifts the dose 
response needed for insulin to stimulate an adequate response and consequently, the 
pancreatic β-cells must produce more hormone to overcome hyperglycemia.  A decreased 
response to the hormone in peripheral tissues such as adipose, skeletal muscle and liver 
causes reduced glucose uptake in these tissues leading to elevated blood glucose levels 
(hyperglycemia).  Further, a hallmark of T2D is that eventually the pancreatic β-cells also 
begin to fail.  These occurrences often lead to supplementation with exogenous insulin to 
help regulate blood glucose, but in the face of insulin resistance, this too may become 
problematic. 
In contrast, T1D is primarily the result of a defect/damage at the level of the 
pancreatic β-cells resulting in an absolute insulin deficiency (4). Hyperglycemia is the 
ultimate end result, but in this case, insulin is not able to either be produced or be 
excreted from the β-cells, yet the peripheral tissues are normally still responsive to it. As 
previously noted, insulin is needed in order for the GLUT-4 proteins to migrate to the cell 
membrane to allow glucose uptake. Therefore, in T1D exogenous insulin 
supplementation is required and usually sufficient to prevent hyperglycemia. This is not 
the case in T2D since they are able to produce but cannot respond adequately to insulin. 
Therefore, T2D must have additional forms of treatment to combat hyperglycemia.  
These may include modifications in diet and or physical activity.  
4 
 
The role of insulin resistance in the pathogenesis of T2D is very important as 
insulin resistance is the initial measurable defect in pre diabetics and diabetics (30). 
Insulin resistance is strongly correlated with obesity and increased plasma free fatty acid 
(FFA) concentrations are typically associated with many insulin-resistant states, 
including T2D (72). Current research suggests that the link between these states is an 
underlying increase in global inflammation associated with obesity.  Increased 
inflammatory molecules may negatively impact insulin signaling (90).  In addition, high 
FFA or triglyceride concentrations are associated with a number of cardiovascular risk 
factors that may be associated with insulin resistance (13), and may contribute to β-cell 
dysfunction in later stage T2D (51). Early in T2D, the body becomes hyperinsulinemic, 
the primary marker for insulin resistance, as the pancreas overcompensates in an attempt 
to return the body to homeostasis (21). As T2D progresses, β-cell function is 
progressively lost. In fact, at the time diabetes is diagnosed, up to 50% of β- cell function 
has already been lost (30). As the body becomes hyperglycemic and the β- cell have to 
work harder to excrete more insulin, this may cause exhaustion of the beta cells leading 
to impaired insulin secretion/ β- cell dysfunction. 
 
 
It has been shown that insulin sensitivity improves when non-diabetic 
overweight/obese individuals lose weight.  This is indicated by a decrease in the plasma 
insulin response to oral glucose and lower plasma triglyceride (TG) concentrations (61). 
It is important to note, however, that even though successful weight loss in 
overweight/obese individuals can ameliorate the consequences and clinical symptoms 
associated with insulin resistance, a number of T2D are not overweight, but are 
categorized as insulin resistant (71). Further, fitness is a better predictor of overall health 
than obesity (93), thereby showing the need for improving physical activity levels in the 
general population.   
1.2 Gender Differences and T2D 
 
 Globally, T2D shows no major overall sex differences (102), however, within the 
late twentieth century, there has been a sex shift in favor of females.  Many studies 
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published before the mid-century show a clear female disadvantage. For example, The 
United States National Health Survey in 1935-1936 reported that almost twice as many 
women were affected with diabetes in comparison to men between the ages of 45-64. 
This was not prevalent in the younger generation (<25years old), however, as age 
increased, so did the prevalence of diabetes in women (82). Since 1950, the number of 
men developing diabetes has increased rapidly decreasing the sex bias toward females. 
Possible explanations for this gender shift include the development of a sedentary 
lifestyle resulting in an increase in obesity in males, and decreasing parity in women (40). 
Currently in Ontario, diabetes is still mostly reported in the elderly population, but the 
rate of diabetes is growing rapidly, particularly in females and those less than 50 years of 
age (47). Similar to past theories, this current gender-shift may be due to the rise in 
sedentary lifestyles and obesity in younger adults (41). Although the prevalence of 
diabetes is presently similar in men and women, an important sex difference to note is the 
powerful risk factor associated with T2D. Diabetic women have a 3 to 6-fold increased 
risk of myocardial infarction versus only a 2 to 4-fold increased risk for diabetic men (39; 
105).  
 
A considerable amount of literature has been done in regards to sex hormones and 
susceptibility to T2D.  When compared to control groups, women with T2D had 
significantly higher levels of testosterone, whereas men had significantly lower levels of 
testosterone(22). Also, adiposity and insulin resistance increase in men who lack 
androgen (79; 80) while testosterone therapy decreases adiposity (14; 50; 81) and 
improves insulin sensitivity (50; 77) in obese men and in men with low testosterone 
levels. Moreover, testosterone has been shown to have more negative side effects in 
women.  Testosterone enables insulin stimulated glucose uptake in muscle, and increases 
lipogenesis in visceral fat (50). Interestingly, while there is a sexual dimorphism for the 
association of plasma testosterone with T2D, endogenous estradiol levels may be 
elevated both in men and in postmenopausal women with T2D. Pre-menopausal females 
have higher estrogen levels that are associated with many benefits including a reduced 
risk of overall mortality (11; 32; 83). Also, estrogen therapy reduces low density 
lipoprotein and increases high density lipoprotein concentrations in postmenopausal 
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women (98), while estrogen deficiency leads to impaired glucose tolerance, increased 
gluconeogenesis, and reduced glycogen content in several tissues (7).  Interestingly, 
estrogen treatment appears to give the same benefits as physical activity in 
ovariectomized rats (73).   
Estrogen is an antioxidant (84), a vasodilator (56), and accelerates endothelial 
growth (57).  These events would limit exercise related oxidative stress and maintain 
blood flow to important areas during exercise.  Females also have smaller catecholamine 
responses to exercise (88).  Not surprisingly then, estrogen has also been associated with 
a reduction in the accumulation of Heat shock protein 70 (Hsp70) after exercise (55; 62). 
The consequences of the lack of a stress response (i.e. increase in HSPs) become apparent 
when male and female rodent hearts are allowed to recover after simulated heart attacks 
after an acute exercise bout (63) or training (89).  Exercised males show enhanced 
recovery over non-exercised males, but this is not observed in females.  Interestingly, 
CVD is the leading cause of death in women, with diabetes greatly increasing this risk 
(5).  Even though estrogen can reduce the appearance and severity of CVD (32), when an 
incident transpires, females experience poorer outcomes, are not able to return to their 
normal quality of life as soon (27; 91) and are more likely to die (92) compared to men 
treated similarly. However, premenopausal women appear to require a greater stressor in 
order to induce a cardiovascular event (15; 70; 75).  Since some of the benefits of 
exercise are likely a result of changes to intracellular proteins, including the HSPs, an 
exercise stress that would overcome the protective effects of estrogen may be needed to 
garner the same benefits as seen in males.  
1.3 Physical Activity and Diabetes 
 
Physical exercise is associated with many physiological benefits for diabetics 
including body weight control, reduced insulin resistance, reduced blood pressure and 
reduced inflammation.  It also increases glycemic control and endothelial function (12). 
Exercise, however, is a physiological stress to which the body must invoke mechanisms 
to maintain homeostasis.  Exercise increases body temperature, and leads to the metabolic 
accumulation of reactive oxygen species, inorganic phosphates and calcium, while 
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decreasing high energy phosphates (8).  Prolonged exercise reduces carbohydrate stores 
(23), and intense exercise may elicit muscle damage resulting in the release of 
inflammatory cytokines (29).  Nonetheless, adaptations to these stresses after chronic 
exercise training or increased physical activity are associated with a reduced risk of 
developing and dying from many chronic diseases including diabetes and cardiovascular 
disease (20; 43). More importantly, the reduction in risk and improvements in fitness 
appear to correlate well with the intensity of exercise (20; 36). For example, 6 months of 
low volume moderate intensity training and high volume high intensity training improved 
insulin sensitivity by 40% and 85% (38), respectively.  Further, physical activity 
enhances whole body insulin sensitivity, resulting in enhanced muscle glucose uptake in 
both healthy and obese insulin resistant animals and humans (2).  
1.4 Glucose Uptake and Physical Activity 
 
Given the health increasing effects of physical exercise, it is plausible to consider 
exercise as a medicine. For example, insulin is used to combat hyperglycemia and allow 
blood glucose to enter cells, and as such, many diabetics are given insulin, especially 
when pancreatic function starts to fail.  However, exercise can elicit the same glucose 
lowering response without the presence of insulin and may actually increase the 
responsiveness of insulin target tissues to this hormone.  Glucose transport into the cell is 
a limiting step for glucose uptake and utilization into skeletal muscle (Figure 1.1 E).  
With exercise and skeletal muscle contraction, the GLUT-4 transporter migrates from its 
intracellular pool to the cell membrane of skeletal muscle and allows glucose to be taken 
in (Figure 1.1 F). It is hypothesized that this effect is initiated by an increase in 
cytoplasmic calcium, and or an increase in AMPK (adenosine monophosphate activated 
protein kinase) (35; 103).Therefore, glucose uptake is increased because of an increased 
number of GLUT-4 receptors on the plasma membrane induced through exercise.  
Increased skeletal muscle GLUT-4 is typically induced through prolonged 
endurance exercise training. Phillips et al. (1996) showed that a training protocol 
consisting of 2h/day cycling at ~60% pre-training VO2peak was able to increase GLUT-4 
content 29% after 5 consecutive days, and 64% after 31 days of continuous training (65). 
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These results confirmed earlier work done by both Gulve and Spina (1995) and Houmard 
et al (1995) who, using similar protocols, but with less volume (5-7 consecutive days) 
found that GLUT-4 content was enhanced by ~100% (33; 37).   
In contrast, Burgomaster et al. (2006) had eight men perform 4 to 6, 30 second 
cycling sprints, followed by 4 minutes of recovery for 3 days a week for 6 weeks and 
concluded that muscle GLUT-4 increased after 1 week of this sprint interval training 
(SIT) and remained 20% higher for a following 6 weeks (17). This was the first study to 
show that interval training increases the content of GLUT-4 in human skeletal muscle 
(17). Interestingly, it has been observed that after an acute bout of exercise, the non-
insulin mediated effects of glucose uptake are reversed after a few hours (31; 104), 
however, insulin sensitivity due to the acute bout remains increased for approximately 1-
2 days (97; 104). 
1.5 Exercise is a Stress 
 
Interestingly, many of the stresses associated with exercise also lead to the 
accumulation of HSPs in several tissues.  In fact, exercise causes an increase in Hsp70 in 
the heart (78), liver (74), brain (100), plasma (25; 46; 99) and skeletal muscle (24)of 
animals as well as humans (53; 58) and this relationship is intensity dependent (49; 54). 
Many of the primary roles of Hsp70 are intracellular and associated with cellular 
survival.  For example an exercise-induced increase in Hsp70 in the hearts of male rats 
was necessary for the improved cardiac function after a simulated heart attack (63). 
HSPs and antibodies against these HSPs are also expressed in the plasma of 
healthy individuals at rest (67) and they have important extracellular functions (9; 52; 
59). However, it is not entirely clear whether circulating HSPs are good or bad.  
Increased circulating levels of antibodies against these proteins (notably Hsp60) are 
found in diseased individuals (34; 60; 68), and they are reduced in people who live for a 
long period of time, (i.e. centenarians) (87). In fact, necrotic cells release HSPs (94) and 
they can act as extracellular cytokines (9; 66), binding to plasma membrane receptors of 
cells and subsequently activating pro-inflammatory cytokines (e.g. tumor necrosis factor 
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(TNF)-α, interleukin (IL)-1β and IL-6 ) (9). In contrast, HSPs also have anti-
inflammatory effects (66) and it is these roles that link HSPs to diabetes. 
1.6 HSPs, T2D, and Gender Differences 
 
Patients with T2D have reduced expression of Hsp70 (19) however, one of the 
risk factors for diabetes, and obesity, also appears to be a state of chronic inflammation as 
the inflammatory cytokines may contribute to insulin resistance (101). Interestingly, mice 
exposed to heat for 15 minutes for 16 weeks showed improved glucose and insulin 
tolerance, inhibition of inflammatory signaling and had better insulin signaling (19). 
Given the known benefits of increased physical activity and the potential role of 
endogenous circulating HSPs in modulating the inflammatory response, the study of the 
potential importance of the exercise related modification of these proteins to T2D 
occurrence and progression may be beneficial. 
It is important to note that males and females differ not only in their physical 
attributes, but differ with respect to the HSPs as well.  Female humans not only have a 
greater amount of extracellular Hsp70 at rest (66), but female mice have greater levels in 
the heart (96). The latter observation is specific to estrogen as its removal by ovariectomy 
reduces while estrogen supplementation increases Hsp70 expression in cardiac cells (96). 
Whether this relationship is similar in the plasma is unknown. 
 
 
1.7 A Practical Model of Physical Activity 
 
Current recommendations for improving markers that are correlated with diabetes 
involve performing moderate to intense aerobic and resistance exercise weekly (44; 45). 
However, compliance with an exercise program remains poor, typically cited as due to 
lack of time (10) and individuals at risk for disease do not adhere to a healthy lifestyle 
greater than those not at risk (42).  Interval training is a time-efficient form of exercise 
that generates similar benefits to long duration, steady state exercise.  Burgomaster et al 
(2005, 2006) have consistently shown that 4-6 sessions of 30 second all out sprints, 
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followed by 4 minutes of recovery (i.e. rest or low intensity exercise) after each sprint is a 
time efficient protocol for improving many of the fitness parameters normally associated 
with aerobic exercise (17; 18). For example, there is anincrease in muscle oxidative 
capacity (17; 18; 28), increased resting glycogen content, a reduced rate of glycogen 
utilization and lactate production during matched-work exercise, and increased total 
muscle glucose transporter 4 protein content (16; 17). Aside from the physiological 
benefits, what is even more remarkable is that HIIT training was 90% and 70% lower in 
exercise volume and time spent training, respectively, compared to endurance training. 
Again, this suggests that HIIT is a time-efficient strategy to improve the fitness of the 
human body and functional exercise capacity, while improving exercise compliance.  
Previous HIIT studies have used an exhausting protocol that consists of “all out” 
efforts (i.e. Wingate-like, super maximum, above VO2 peak) protocols on their 
participants. This type of training is very demanding and taxing on the body. 
Consequently, it may neither be a safe nor efficient protocol for those individuals with or 
at risk for various diseases.  Further, because of the exhausting nature of the bouts, 
individuals may not be as compliant to perform the exercise. Recently, a few 
modifications have been done to the original protocol.  For example, in 2 weeks, 
participants performed 6 sessions of HIIT with each session consisting of 8-12 60s 
intervals at approximately 100% peak power output, separated by 75s of recovery. Both 
exercise performance, and mitochondrial activity were improved as well as an increase in 
total GLUT-4 content in skeletal muscle (48). In light of this, our primary purpose was to 
implement a similar but modified protocol to that used by Burgomaster et al (2005) that 
is more practical and safe, yet still time-efficient (18).  
Lower intensities of HIIT have been effective for inducing metabolic adaptations 
(64; 85), however their interval sessions were greater than 60 min in duration, and 
therefore were not a time-efficient method that would help increase exercise compliance.  
How low of an intensity that can be utilized within this same protocol to still observe 
these improvements has yet to be determined.  Further, two populations are significantly 
underrepresented with respect to these exercise regimens:  diseased individuals and 
women.  As mentioned above, physical activity reduces the risk factors for diabetes 
including obesity, but also can independently improve glucose handling (36).  Given the 
11 
 
proven benefits of high intensity interval training in fitness improvements in normal 
individuals, the potential benefits and increase of protective proteins (e.g. Hsp70), as well 
as the short duration of this mode of exercise, examination of the response to high 
intensity interval training in diabetic individuals is not without merit.  Further, whether 
diabetic females will respond to interval training in a physiologically relevant manner has 
not been reported.     
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Chapter 2. Manuscript 
2.1 Introduction 
Cardiovascular disease (CVD) is the number one cause of death in both Canadian 
men and women, with diabetes greatly increasing this risk. More importantly, the 
increase in diabetes diagnoses have already exceeded the 65% Canadian increase that was 
predicted to occur within 35 years from 1995 to 2030 (35).  There is an overwhelming 
body of evidence confirming the benefits of exercise as a prevention against and 
treatment for diabetes. Exercise elicits a change in many proteins and has many 
physiological benefits that improve glucose handling, thereby improving the diabetic 
state and potentially protecting against its related diseases such as CVD. Current 
recommendations for improving markers that are correlated with diabetes include 
performing moderate to intense aerobic and resistance exercise weekly (23; 24). 
However, compliance with an exercise program remains poor, typically cited as due to 
lack of time (3; 17) and individuals at risk for disease do not adhere to a healthy lifestyle 
greater than those not at risk (21).   
Interval training is a time-efficient form of exercise that generates similar benefits 
to long duration, steady state exercise.  Several studies (e.g. Burgomaster et al (2005, 
2006) have consistently shown that 4-6 sessions of 30 second all out sprints, followed by 
4 minutes of recovery (i.e. rest or low intensity exercise) after each sprint is a time 
efficient protocol for improving many of the fitness parameters normally associated with 
aerobic exercise (e.g. increased GLUT-4 and muscle metabolic enzymes)(8; 10). These 
physical and metabolic adaptations can reduce the risk of many chronic diseases and 
illnesses such as obesity and Type 2 diabetes (T2D).  What is more remarkable is that 
these physiological benefits are seen in high intensity interval training (HIIT) which is 
typically 90 and 70% lower in exercise volume and time spent training, respectively, 
compared to endurance training. Therefore, HIIT is a time efficient modality that can 
improve many markers associated with diabetes, including insulin sensitivity, but has not 
been tested in a diabetic population. In fact, a recent review on the participant has 
indicated the need for HIIT testing in a clinical population and suggested that this may 
act as a bridge to further exercise performance (16). 
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Current recommendation for improving diabetes, cardiovascular disease, and the 
metabolic syndrome involve performing 30 minutes of moderate exercise as many of the 
days a week as one can (24).  Though this may appear to be a simple task, the general 
population fails to adhere to such guidelines due to lack of time. This suggests that a new 
intervention may need to be imposed where one can receive similar benefits in a time -
reduced fashion. HIIT is normally associated with “all out” physical efforts and for many 
T2D who possess characteristics associated with the metabolic syndrome, including 
overweight, obesity and physically inactivity, this may be too difficult to perform. 
Recently, however, a lower volume HIIT consisting of a total commitment of 2 h and 25 
min of exercise over 2 weeks also improved aerobic fitness and increased important 
metabolic enzymes similar to the previous HIIT studies (25). 
 Lastly, females are underrepresented in the scientific community and many of the 
HIIT based studies have included only males or not reported/analyzed sex differences in 
its benefits. Not only is it unclear if HIIT based adaptations will occur in a diseased 
population, but it is also unreported whether females will respond to HIIT in a similar 
fashion to men.  Consequently, the purpose of this study was to observe whether 
metabolic adaptations would occur as a result of lower intensity HIIT (100% VO2max) in a 
clinically relevant population (i.e. T2D) that included women.  
 
2.2 Hypotheses and Objectives 
The objective of this experiment was to determine if interval training can improve 
insulin sensitivity in adult male and female T2D.  Based on the experiment of 
Burgomaster et al (2005) and others who observed significant changes in fitness, skeletal 
muscle glucose proteins and metabolic control in healthy individuals after as little as 1 
week of HIIT (3; 7-10; 15; 20), it was hypothesized that exercise interval training would 
improve insulin sensitivity in both female and male diabetics and that this would be 
accompanied by an increase in fitness (i.e. increased VO2max). 
2.3 Methods 
Participants 
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Eleven sedentary adults, consisting of 8 females and 3 males, who were diagnosed 
by their physicians as having T2D for at least 1 year participated in our study. Baseline 
characteristics are outlined in Table 2.1.  All participants were free of the following 
complications associated with diabetes as determined by their physician: arthrosclerosis, 
coronary artery disease, history of myocardial infarction or stroke, hypertension (systolic 
blood pressure >165/95 mm Hg), diagnosed kidney damage, osteoporosis, orthopedic, 
rheumatological or physical limitations that prevent the use of exercise equipment, fatty 
liver disease, central or peripheral nervous system disorders (tingling, numbness, burning 
or pain in the eyes and or legs) or respiratory diseases.  Further, none of the participants 
were intending to change their diet nor were they engaging in or planning to engage in 4 
or more planned exercise sessions per week of vigorous activity in addition to the 
experimental protocol. Medications to lower lipid levels were allowed if the regimen was 
maintained throughout the trial. Also, participants who took any medications that 
contained cortisone steroids or secretagoges were excluded as these could impact blood 
glucose levels even after withdrawal. All testing and exercise training was performed in 
the Physical Activity and Cardiovascular Research (PACR) laboratory at the University 
of Windsor. Participants were informed and debriefed about the experiment verbally and 
in writing, and read and signed an informed consent prior to testing (see Appendix C). 
Further, participants were required to read, sign and have their physician complete the 
Physical Activity Readiness Medical Examination (PARmed-X, see Appendix B) 
questionnaire and drug withdrawal forms (Appendix D) before partaking in the training 
program. All participants were asked to maintain their normal diet and activity levels 
throughout the duration of the study. This experimental protocol was approved by the 
Research Ethics Board at the University of Windsor (Appendix A).   
 
Assessment of Fitness and the Leisure Time Exercise Questionnaire (LTEQ) 
At each test, participants were required to complete the Godin Leisure Time 
Exercise Questionnaire (LTEQ, see Appendix E).  The LTEQ is a simple, self-
explanatory questionnaire that estimates leisure time physical activity.  It has been 
validated and proven reliable in a number of studies (for review and validation see Godin 
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& Shepherd, 1997) (18; 27).  The LTEQ requires that participants report on how many 
days in the previous 7 days they have engaged in strenuous physical activity (e.g. 
jogging, running, basketball), moderate physical activity (fast walking, baseball, 
volleyball) and mild exercise (e.g. yoga, golf, fishing) for more than 15 minutes of their 
free time.  Weekly frequencies of strenuous, moderate, and light activities are multiplied 
by 9, 5, and 3METs, respectively. Total weekly leisure activity is calculated in arbitrary 
units by summing the products of the separate components.  The formula is outlined 
below: 
 
 
 
On days 1, 14, and 29 participants performed a submaximal V02 test during which 
blood draws were taken.  Upon arrival to the PACR lab, each participants height (m) and 
weight (kg) were measured and used to calculate BMI (weight(kg)/height(m)2). 15 
minutes prior to exercise, blood glucose was measured through venipuncture, which was 
performed by a registered nurse using sterile technique. If blood glucose was below 
5.5mmol/L, participants were given 4 ounces of fruit juice and refrained from exercising 
for 15 minutes at which time blood glucose was checked again.  Participants were 
required to wear a telemetric heart rate monitor for determination of resting heart rate 
(HR) (Polar Canada).  The participants mounted an Ergoline cycle ergometer (i.e. 
stationary bicycle) and the seat height and handle bar distance were adjusted for comfort 
and proper positioning of the participant. After a 5 minute period of non-activity, resting 
HR was recorded.  Subsequently, participants performed an incremental (25W/3min, 
60rpm) cycling test to ~75% predicted max HR (i.e. 220-age).  Data from this test was 
used to estimate their maximal oxygen uptake (VO2max) by the procedures below.   
 Cullinane et al. 1988, devised a mathematical method for calculating VO2max  that 
was based on a modified version of the Åstrand-Rhyming sub-maximal test (12; 31). 
Basically, this estimation is based on the linear relationship between HR and VO2max (i.e. 
for each increase in VO2max there is a corresponding increase in HR).  By following the 
above protocol, we determined each participant’s final work rate and steady-state heart 
Equation 1: 
Weekly leisure activity = (strenuous x 9) + (moderate x 5) + (mild x 3) 
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rate which was entered into a series of equations to determine estimated VO2max.   First, 
the heart rate at the final stage was used to determine the percentage of VO2max the 
participant was working at (equation 2). 
 
 
Subsequently, the absolute V02 associated with the final work rate was predicted. The 
value for men was extrapolated from Åstrand’s 1960 nomogram (2) while for females 
this was predicted from the following equation (equation 3).  
 
From the absolute VO2 at the final work rate, V02max uncorrected for age was estimated 
using the following equation (equation 4). 
 
 
 
 
 
Equation 2: 
Males % V02max = 0.769 x HR (b/min-1)-48.5, 
Females % V02max = 0.769 x HR (b/min-1)-56.1 
Equation 3: 
Females V02 (L/min-1)= 0.00193 x work rate (kpm/min-1) + 0.326 
Equation 4: 
(V02 for work rate (L/min-1) / %V02max) x 100 
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Finally, V02max was corrected for age using the following equation (equation 5). 
 
 
By extrapolating to predict maximum HR, maximum work rate was also predicted and 
used to set an intensity for the interval bouts during the training portion of this 
experiment.   
Immediately after exercise, blood glucose was again checked using a standard 
glucose monitor (FreeStyle Freedom Lite) and fingerstick blood to ensure hypoglycaemia 
was not present.  If found, participants were given 4 ounces of fruit juice and blood 
glucose was checked again at 15 minutes and monitored until blood glucose rose to above 
5.5 mmol/L.  
Assessment of Diet 
Participants were asked to complete the online Eating + Activity Tracker 
(eaTracker) system for dietary analysis during the first and third submaximal VO2 test. 
The eaTracker is an online food and activity analyzer located on the Canadian dieticians’ 
website (http://www.dietitians.ca). 
 
Interval training 
Within 5 days of the second submaxVO2 test, and after the initial first 2 weeks, 
participants commenced a 2 week interval training program (Figure 2.1).  The program 
consisted of 3 bouts of interval training per week.  Each bout entailed 4 repeated 30-s 
cycling sprints at a work rate equivalent to 100% VO2max that was predicted from the 
VO2max tests (see above).  The cycling sprints were interspersed with 4 min recovery 
periods at 25% of predicted VO2max.   This intensity typically resulted in HR increases to 
~85% of HR max (see figure 2.2).  Blood glucose was monitored by fingerprick before 
Equation 5: 
Males V02max (L/min-1)= 0.348 x V02max uncorrected – 0.035 x age + 3.011 
Females V02max (L/min-1)= 0.302 x V02max uncorrected – 0.019 x age + 1.593. 
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and after exercise and HR was measured continuously throughout the test using the Polar 
HR monitors.  Two to 3 days after the last training session, participants underwent the 
procedures outlined in the assessment of fitness section above. Before starting the test, 
participants were informed they could discontinue cycling and the test would be 
terminated if ever they felt like they couldn’t precede or felt any feelings of discomfort. 
Participants were continuously monitored throughout the test and were verbally 
encouraged and motivated to finish each interval bout. Two investigators were always 
present to ensure each participant is able to perform the test without any signs of distress 
and discomfort.  
 
Blood Collection 
Blood was collected on 3 separate days:  on the day of the initial submaxVO2 test, 
2 weeks after the initial test (2nd submaximal VO2 test) and 2-3 days after the last interval 
training bout on the same day of the post-training submaxVO2 test. Participants were 
asked to stop performing any type of physical activity and to stop taking any glucose 
lowering medications for 48hours (according to their physician’s guidelines) prior to the 
test, and to attend the laboratory in the morning (between 8-11am) in a fasted state (6-12 
hour fast). Venipuncture was performed by a registered nurse using sterile technique.  A 
21gauge butterfly needle (BD) (BectinDinckinsin, Utah, USA) was inserted into the 
antecubital vein and whole blood was collected into K2EDTA plasma collection tubes 
(4mL) (BD) and uncoated serum collection tubes (4mL) (BD) both before and after the 
VO2max test.  Prior to separation, a portion of the EDTA blood was drawn into plastic 
capillary tubes for immediate hematocrit and glycated haemoglobin (HbA1c) 
measurement, using a micro hematocrit centrifuge (CritSpin) with manual card reader 
and the In2it HbA1c analysis system (Bio-Rad), respectively.  Blood in serum collection 
tubes were allowed to clot at room temperature for 30 minutes prior to centrifugation at 
3500 rpm for 10 minutes and careful aspiration of serum.  Plasma was separated by 
centrifugation of EDTA blood samples at 3500 rpm for 10 minutes and then stored at -
75ºC until analysis of glucose, insulin, triglycerides, cholesterol, hormones and heat 
shock proteins.   
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Assessment of plasma glucose and insulin 
Whole blood glucose was determined before and after each exercise session using 
a commercially available Freestyle Freedom Lite blood glucose monitoring system 
(Abbott Laboratories) on fingerprick blood samples.  This machine measures blood 
glucose within 5 seconds and utilizes only 10 µL of whole blood.   
Plasma glucose concentrations for HOMA-IR analysis were measured using an 
enzymatic reaction in a GL-5 analyzer (Analox Instruments) utilizing 10 µL of plasma 
from venous blood samples. Glucose concentration was determined after calibration of 
the GL-5 analyzer with a known glucose standard. 
 Plasma insulin concentrations were determined by a sandwich ELISA 
(Invitrogen) using 50 µL of sample in anti-insulin coated wells of a 96-well microplate. 
After incubating the plate with continuous shaking for 30 minutes, and washing the plate, 
100 µL of the Stabilized Chromogen Solution was added to each well and incubated for 
15 minutes with continuous shaking.  Then, 100 µL of stop solution (0.2 M sulphuric 
acid) was added to each well to inhibit the reaction and stop colour development. 
Absorbance was measured at 450 nM using a SyngergyHT spectrophotometer (BioTek).  
Results were then compared to a standard insulin curve. The detection limit for insulin 
using this procedure is 0.17 µIU/mL. 
 
Assessment of insulin resistance 
Homeostatic modelling assessment of insulin resistance (HOMA-IR) was 
accomplished using computer models (HOMA2) outlined by (33).  These incorporate 
fasting plasma glucose and insulin concentrations (33) and is used to give an estimate of 
insulin sensitivity and β-cell function by establishing a relationship between hepatic 
glucose output and insulin secretion. HOMA2 is a computer based non-linear model that 
takes into account hepatic and peripheral glucose resistance.  
 
Assessment of plasma triglycerides and cholesterol 
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Plasma triglycerides were determined using a series of enzymatic reactions in a 
GL-5 analyzer (Analox Instruments) utilizing 25 µL of plasma from venous blood 
samples.   Triglyceride concentrations were determined after calibration of the GL-5 with 
a known triglyceride standard and changing to reagent kits (i.e. buffers and enzymes) 
specific to this analyte (Analox Instruments). 
Total and free plasma cholesterol were determined using a series of enzymatic 
reactions in a GL-5 analyzer (Analox Instruments) in 3.5 µL of untreated plasma samples 
(free cholesterol) or plasma samples that had been treated with cholesterol esterase (total 
cholesterol).   Cholesterol concentrations were determined after calibration of the GL-5 
with a known cholesterol standard and changing to reagent kits (i.e. buffers and enzymes) 
specific to this analyte (Analox Instruments). 
Glycated Hemoglobin measurement 
Glycated hemoglobin (HbA1c) was measured using the In2it HbA1c analysis 
system (Bio-Rad).  This system utilizes 10 µl of EDTA plasma to determine HbA1c 
within 10 minutes.  
 
Plasma Anti-Hsp60 levels 
Plasma antibodies against the heat shock protein Hsp60 was assessed by a 
commercially available sandwich enzyme linked immunosorbent assay (ELISA, 
AssayDesigns).  Briefly, 100 µL of each sample will be incubated in antibody (specific 
for anti-Hsp60) coated wells of a 96-well microplate for 2 hours.  After washing the 
plate, 100 µL of HRP conjugated antibody was pipetted into each well and allowed to 
incubate for 1 hour. Subsequent to another series of washes, 100 µL of TMB Substrate 
solution (3, 3’,5,5’ tetramethylbenzidine (TMB) and hydrogen peroxide) was added, 
allowed to develop for 15 minutes and the reaction was stopped with the addition of 100 
µL of stop solution (1N solution of hydrochloric acid in water) to each well.  Absorbance 
of each well at 450 nM was measured and absorbance values was compared to a standard 
curve of known Hsp70 concentrations. The sensitivity of the assay is 2.88 ng/mL. 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Sex Hormones  
Estradiol and progesterone (Cayman Chemicals) were examined using 96-well 
enzyme immunoassays (EIA) kits performed according to the manufacturer’s guidelines.  
Briefly, hormone concentrations are determined by the competitive binding of hormone 
in the sample plasma and a labeled hormone conjugate for a limited amount of hormone 
anti-serum.  Plasma samples with greater hormone concentrations will outcompete the 
labeled hormone and consequently, will result in less color developed in each well.  The 
color developed was measured using a SynergyHT spectrophotometer (BioTek) at a 
wavelength of 405 nM and then compared with a standard curve made from known 
standard concentrations of hormone.  The detection limits for the estradiol and 
progesterone kits are typically 19 and 10 pg/ml, respectively.  
 
Statistical Analysis 
All statistical analyses were performed using PASW version 18 (formerly SPSS).   
All data including descriptive statistics is presented as means and standard deviations 
(SD) unless otherwise noted.   The data for primary and secondary outcome measures 
was compared using an analysis of covariance (ANCOVA) with repeated measures on 
the factor of time.  The independent variable of time consisted of 3 timepoints:  initial 
(T0), 2 weeks of normal activity (i.e. no intervention) and immediately prior to training 
commencement (T1) and after 2 weeks of interval training (T2). For the analysis of blood 
glucose changes following each HIIT bout, a 2 factor (time: pre versus post x bout: 1st 
versus 2nd versus 3rd versus 4th versus 5th versus 6th) ANCOVA was used.  Hormonal 
status (progesterone/estradiol ratio), BMI, age, and cardiorespiratory fitness (VO2max) 
were analyzed as covariates that could possibly affect the primary measure of HOMA-IR.  
Upon finding significant interactions or main effects, pairwise comparisons were made 
using Tukey’s post hoc analysis when more than 3 groups were present.   Mean 
differences were considered statistically significant where p <0.05. 
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2.4 Results 
Descriptive Statistics  
 Patient characteristics are outlined in Table 2.1.  12 participants were willing to 
participate in our study, but out of those 12, 1 was excluded prior to the intervention due 
to dependence on caregivers while 2 performed all aspects of the study including exercise 
training, but upon blood analysis had undetectable insulin levels. Consequently, complete 
data sets could only be collected from 9 participants.   
 
Exercise and Nutrition Compliance   
There were no significant differences in either dietary intake or outside exercise 
participation. Mean caloric intake for T0 and T 2 were, 1256.44±577.34 and 
1375.44±482.99 F (1, 8) =0.52 (p>.05) with no between group differences.  Mean leisure 
time exercise outputs recorded at each test were as follows, 14.89±SD 16.59, 
14.11±11.48 and 12.78 ± 11.26, F (2,16)=. 21 (p>.05) with no between group differences.  
Blood Glucose Response to HIIT  
Blood glucose levels were reduced after each training session F (1,8) = 17.97 (p 
<0.05) (Figure 2.3).  
 
 
Exercise Capacity 
Predicted VO2max was significantly greater when measured after training (p<0.05) 
compared with the initial test (1.95L/min± .64 versus 2.05L/min± 0.70, respectively) with 
F (2,16)=4.16(p<. 05), but was not different than the second test. ).Post hoc analysis 
reveals test 1 is significantly different then test 2 and test 3 with p = 0.13, .02, and .51 
respectively. Predicted VO2maxhad a small –medium effect size of .34, and a power of .7.  
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Further, there were statistically significant differences in relative VO2max at the same 
timepoint with means of each test being 19.55L/min± 4.13, 20.28L/min± 4.11, and 
20.46L/min ± 4.56 with F (2, 16) =4.55 (p<. 05). Post hoc analysis reveals test 1 is 
significantly different then test 2 and test 3 with p = .01, .01, .68 respectively. Similar to 
predicted VO2max, Relative VO2max had an effect size of .36 and a power of .69 
Serum Insulin and Plasma glucose (mmol/L) 
Of the 11 participants who completed the test, 2 had undetectable insulin levels as 
measured by EIA.  As such, these 2 participants were excluded from our analysis.  
Neither serum insulin (29.39± 17.69, 27.70±10.33, 22.16± 12.51 with F (2, 16) =1.42 
(p>.05)) (Figure 2.4 A) nor plasma glucose (8.73± 2.87, 8.69±3.01, 8.85± 3.65 with F 
(2,16) =.039 (p>.05)) (Figure 2.4 B)  concentrations were significantly different between 
any test.   However, after training at test 3, there was a trend for serum insulin levels to be 
reduced.  Particularly, 6 out of the 9 participants had a reduction in serum insulin levels 
after training (Appendix F). Insulin had a small effect size of, 15 and a power of .2, and 
.005 and .06 respectively for glucose.  
HOMA-IR  
No significant differences were observed in HOMA-IR either before or after 
training (4.1 ±2.2, 4.0 ± 1.4, and 3.2± 1.7 for T0, T1 and T2, respectively) F (2,16) = 
1.48(p>.05) (Figure 2.4 C). However, as with insulin above, there was a trend for 
HOMA-IR to be reduced following training.  In fact, 6 of the 9 participants showed 
reduced HOMA-IR levels (Appendix F). Moreover, our study demonstrated a small to 
medium effect size of .16, and a power of .21.  
The HOMA-IR calculation also allows an estimate of β-cell function (99.89± 
61.96, 102.71± 57.71, 86.94± 52.15 for T0, T1 and T2, respectively) but no significant 
differences were observed F (2,16) =1.13 (p>.05)) (Figure 2.2 D).  This was also the case 
for insulin sensitivity (32.36± 18.98, 28.42± 9.65, 39.89± 19.72 for T0, T1 and T2, 
respectively) with F(2,16) =1.55 (p>.05))  (Figure 2.2 E). Similar to HOMA-IR, β-cell 
function had a small to medium effect of .12 and a power of .21 and insulin sensitivity 
had an effect size of .16 and a power of .12.  However, a significant contrast (non-linear, 
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F (1,8) = 5.767(p< .05) was observed for insulin sensitivity which would tend to support 
our observation of a trend for improvement in this measure. Following this contrast and 
further supporting our trend, insulin sensitivity contrasts demonstrated a medium to large 
effect size of .42 and a power of .56. 
HbA1C, circulating triglycerides and cholesterol 
There were no significant differences in HbA1C, plasma triglycerides and free or 
total plasma cholesterol at any time point.  Means and F values are reported in Table 2.2.  
Anti-heat shock proteins 
There were no significant differences found between any timepoint for serum 
antibodies against Hsp60, the major HSP associated with diabetes. In fact, the levels of 
antibodies against Hsp60 were remarkably consistent over time within individuals 
(65.97±81.84, 65.19±82.27 and 64.32±74.13 for T0, T1 and T2, respectively).  
Unfortunately, after all analyses were completed, there was not enough serum remaining 
to analyze other HSPs. 
2.5 Discussion 
Physical exercise is a potent method of reducing the risk of several major chronic 
human diseases including diabetes and cardiovascular disease.  In fact, the American 
College of Sports Medicine annual Conference was recently titled, “Exercise is 
Medicine” to push for the treatment of exercise in the same way as most pharmaceuticals 
such that the range of exercise doses (intensity x duration) and modalities necessary to 
promote health are characterized.  As such, the current study adds to this knowledge base, 
notably in a diseased population.  Using a lower training intensity than previous interval 
training studies, we did not find significant improvements in fasting insulin, HOMA-IR, 
insulin sensitivity or ß-cell function after 2 weeks of training, however, we do report 
trends for improvement in many of these measures after this low volume training.  
The concept of using physical activity to promote metabolic adaptations in T2D is 
not a novel concept. Exercise training induces many metabolic and morphological 
adaptations in skeletal muscle, including an increase in the number of GLUT-4 
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transporters at the muscle membrane. Consequently, this increases glucose transport into 
skeletal muscle and is notable because an insulin mediated stimulus is not required. 
However, exercise also increases the sensitivity of muscle to insulin so that a lower 
insulin dose will cause the same or greater removal of glucose by muscle.  In support of 
this, we did observe that each HIIT bout was able to significantly reduce blood glucose 
(BG) immediately after the exercise session and in a hyperglycemic population as 
confirmed by elevated levels of both fasting BG and HbA1c (Figure 2.3 and Table 2.2). 
Interestingly, Burgomaster et al.(7) reported that skeletal muscle GLUT-4 levels 
increased by ~20% after one week of HIIT, and remarkably remained elevated over 6 
weeks of training and a subsequent 6-week period of detraining. Given that we also used 
HIIT, but at a slightly lower intensity, and observed a reduction in BG levels after each 
training session, an increase in GLUT-4 at the skeletal muscle membrane may have partly 
explained these findings.  Although a drop in BG has been reported in T1D and T2D with 
intense exercise, this is the first study to demonstrate that BG levels drop after HIIT 
(100% Vo2max), which consists of a relatively little time (only 30 seconds per interval and 
therefore a total of 2 minutes) of intense exercise.  It is unknown how long this reduction 
lasted after each bout, but likely this maintained for some period afterwards.  
Interestingly, similar reductions are accomplished using pharmacological injections of 
insulin.  As such, exercise is able to accomplish the same result as a pharmacological 
intervention and further supports the notion of exercise as a medicine.  Further studies are 
required to determine how long the exercise induced reduction in BG lasts. Not 
surprisingly, HbA1c (a measure of chronic BG elevation) did not change in the 2 weeks 
of our intervention. However, repeated drops in BG with this type of training may alter 
HbA1c given a longer training period.  
To date, research (3; 29) has shown that exercise training improves insulin 
sensitivity, but not glucose control. Though not significant, we found a trend for a 
reduction in serum insulin following training but no such trend in blood glucose (refer to 
figure 2.4 A and B). Although immediate improvements are likely due to exercise 
stimulated translocation of GLUT-4 to the membrane, part of this response and longer 
adaptations may include increases in insulin mediated glucose uptake. A recent study 
indicated that exercise enhances insulin-stimulated glucose uptake (29).  More 
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specifically,  6 sessions of 4-7 , 30 sec max intervals interspersed with 4 minute rest 
periods over a 2 week period augmented insulin sensitivity  (determined via 
hyperinsulinemic euglycemic clamp method) in healthy adults (29). Interestingly, in the 
present study, a significant contrast in insulin sensitivity was observed which fit to a non 
linear equation.  This is an important observation because it suggests that exercise of this 
dose may have the potential to increase insulin sensitivity.  Interestingly, insulin 
sensitivity (determined via OGTT) was improved in overweight/obese men for 24 hours 
following sprint interval training (SIT) but not 72 hours (34). This and the current 
findings suggest that more research is needed to examine the timeframe in which these 
improvements last or are at maximum in a diseased population.    
 In the past it has been shown that the biochemical adaptations (i.e. increase in 
GLUT-4) necessary to improve insulin resistance occur in as little as 1 to 2 weeks. 
Further, 2 weeks of HIIT, the area under the plasma glucose and insulin time curves 
following an OGTT (oral glucose tolerance test) were all reduced (3). The differences 
between this study and those previous may account for the lack of significant 
improvements in HOMA and other health indicators observed presently: the current 
protocol used lower resistances for the high intensity intervals; the participants in the 
present study were already diagnosed diabetic and predominantly female, and an estimate 
of insulin resistance (i.e. HOMA-IR) was used versus more direct measures (e.g. oral 
glucose tolerance test). With respect to the last point, it should be noted that the 
aforementioned study observed significant improvements in glucose handling in healthy 
males, but fasting plasma insulin and glucose concentrations remained unchanged (3).  
Consequently, this may suggest that the HOMA model was not sensitive enough to detect 
early improvements in glucose handling versus a more invasive and time consuming 
OGTT or in vitro glucose tolerance test (IVGTT). Moreover, the response to HIIT may 
be different in females, the exercise intensity of the current study was not high enough to 
elicit significant changes in insulin resistance and/or due to the nature of the lower 
resistance used, a longer duration (greater than 2 weeks) may have been needed to 
observe more dramatic effects. However, although no significant improvements after 
HIIT were observed in the present study, several interesting trends and relationships 
deserve to be noted. First, 6 of the 9 participants who had measurable insulin levels 
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showed improved HOMA-IR measurements after the 2 weeks of HIIT. Further, a closer 
examination of the data indicated that the participants who began the study the most 
metabolically challenged (poor glucose control as noted by a poor HOMA value) tended 
to show the greatest improvement in HOMA at the end of the study (Figure 2.4 C). In 
fact, there was an average drop of 0.85 in the estimated HOMA level after the exercise 
intervention. It has been shown that a drop of 1 point in the HOMA value results in a 
significant reduction in cardiovascular disease (6). Consequently, it may be important for 
future studies to more closely examine the different responses between those diabetics 
with low, moderate and high initial HOMA-IR values. HOMA –IR presented a small 
effect size at .15 and a power level of .35.  Future studies should examine larger sample 
populations while anticipating similar changes in HOMA-IR. 
To further examine the influence of HIIT on insulin sensitivity, we measured 
plasma triglycerides as they have an inverse relationship with insulin sensitivity (30). 
High levels of circulating triglycerides may be a cause of some forms of insulin 
resistance (14; 28). In the present study, plasma TG levels did not change after 2 weeks 
of HIIT, although they trended downward as well. This finding is supported by two 
previous studies following a similar protocol (3; 34). However, although fasting fatty acid 
concentrations remained unchanged, Babraj et al. (2009), found a decrease in non-
esterfied fatty acids (NEFA) post exercise training (3). This suggests that future studies 
should monitor the effects after each bout of HIIT. As we saw a decrease in BG levels 
after each bout, these markers associated with insulin sensitivity may also be reduced. 
Repeated drops of NEFA as well as glucose (which was observed in the present study) 
may eventually lead to more lasting adaptations and significant health improvements. 
Similar to the results found for TG, we did not see a change in free and total cholesterol 
levels. This was expected, as longer duration studies are needed in order to see 
improvements in both cholesterol and TG levels. Nonetheless, our participants were at 
the higher end of the normal range in both blood analytes, confirming they had a 
disorder.  
Aerobic physical activity may improve β-Cell function in prediabetics, and those 
with T2D.  However, the effects of short term interval exercise in individuals with T2D 
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have yet to be examined. A recent study using diabetic rats showed that 30 min of 
swimming 5 days a week improved β-Cell function by increasing β-Cell Mass (22). 
Moreover, it has been shown that short-term exercise not only improves insulin 
resistance, but also significantly enhances β-cell function in older people with  impaired 
glucose tolerance (IGT) (5). Although these studies do not support our findings, it is 
important to note the average age of our (39 yrs vs. 68 yrs) participants as well as the 
different protocol used (HIIT vs. 60 minutes of activity).  Further, it was observed in the 
present study that β-Cell as determined by HOMA tended to be decreased (Figure 2.4 C).  
This suggests that the pancreas was becoming less worked/stressed and presents another 
avenue for future research. Studies (22; 5) have shown improvements in insulin 
sensitivity, however, none to date have observed an improvement in β-cell function using 
HIIT.  
Low aerobic exercise capacity appears to be the strongest predictor of mortality 
(26). Our current study demonstrates an improvement after HIIT in both absolute and 
relative V02max based on a predicted sub maximal test. All participants were able to 
perform this test, and this is a method of testing their VO2max at home without any special 
and expensive equipment besides a heart rate monitor and method of determining watts 
(working rate). Epidemiological observations suggest that it may be more important to 
become fit than to lose weight (4; 32). Our participants did not lose weight in a two week 
period, however, their fitness may have improved thereby reducing their risk for CVD. 
Obesity and aerobic capacity are two strong predictors both independently and together 
for CVD and mortality, however the links between aerobic capacity and mortality have a 
greater effect. This suggests that focusing on improving ones aerobic capacity is more 
important than weight loss as poor aerobic capacity puts one at a greater risk for CVD 
and mortality. 
This is a novel study that examined the effects of HIIT on insulin resistance in 
T2D.  It is the first to show that blood glucose is significantly reduced in T2D 
immediately following HIIT (100% Vo2max) and may have significantly improved V02 in 
a diabetic population. With the rapid increase in overweight, and obesity, T2D has 
become an epidemic, leading to cardiovascular complications (the leading cause of 
40 
 
death), and an increase in economic costs.  Not all complications associated with T2D 
can be treated with pharmaceutical agents for glycemic control, and whether this 
intervention has long term beneficial effects is still unclear. Regular exercise training has 
been established being one of the most beneficial interventions to reduce glycemic 
control. Although the benefits of exercise have been well stated, most individuals fail to 
meet the current guidelines. As the recommendations tend to require a few hours a week, 
and lack of time is the main reason for this un-compliance, HIIT has evolved.  The time 
commitment of the exercise protocol we employed may also help to reduce the non 
exercise compliant nature of diabetics as it is only 20 minutes of activity, three times a 
week.  Furthermore, the trends that we did observe warrant further investigation of this 
type of exercise protocol in the improvement of factors associated with metabolic 
diseases and diabetes.   
 
2.6 Conclusion 
In summary, 18 minutes of lower intensity, HIIT distributed over two weeks did 
not improve HOMA-IR. However, given the promising trends for improvement as well as 
the effect sizes calculated, this study is important as pilot data for future studies in 
exercise mediated metabolic improvements.  Further, no study has yet to report data on 
HIIT and a T2D population, and this study serves as a baseline study to set potential 
exercise protocols and prescriptions for future experiments.  
2.7 Limitations and Future Directions 
 While Burgomaster et al (2008) observed muscle metabolic changes after 2 weeks 
of sprint interval training, the time of our exercise intervention (2 weeks) may not have 
been long enough for us to observe significant changes in the measures we chose to 
examine (9). Significant reductions in anthropometric measurements may require a 
longer training period to undergo significant modification and the extent of HOMA 
changes with this training protocol are unknown.  Insulin sensitivity is influenced by fat 
free mass as a reduction in body fat is associated with improved insulin sensitivity and 
blood glucose/insulin measures (1; 13). Therefore, if we were able to decrease body fat, 
we may have seen a greater improvement in HOMA-IR.  Given that body mass did not 
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change in our study as well as previous studies (3), it is difficult to speculate that body 
composition can change with HIIT. Future studies should examine this effect as it is an 
area highly under-researched. Nevertheless, most of the changes in HOMA-IR with 
aerobic type training over longer periods appear to occur very early before stabilizing and 
our study was able to observe a trend for future studies. Due to the wide dispersion of 
HOMA-IR values, this suggests that future studies either employ a cut off value, or 
designate individuals to certain groups based on HOMA-IR values.  
Further, as noted in the discussion, several of the studies that have observed 
significantly improved glucose handling have utilized the more sensitive, but more 
invasive and time consuming methods of either an oral or in vitro glucose tolerance test.  
These methods of determining the body’s homeostatic response to a glucose load could 
be employed in future studies to more closely analyze changes in glucose handling.   
 
The inclusion of both male and female participants is normally viewed as a 
strength in experiments.  The present study consisted of predominately female 
participants and consequently, did not allow us to have an accurate gender comparison. 
Nonetheless, as females are often not included in studies, this is the first study to evaluate 
HIIT using not only T2D, but T2D who are female.  Although the data is unclear whether 
there is are sex differences in the response to exercise training in insulin sensitivity (11; 
19), we did not observe a trend for a difference to occur and it appeared that those 
individuals who started the study with the highest HOMA (poor glucose control) values 
showed the greatest improvements.  Moreover, the participants in this study were all of 
approximately 40 years of age. Given our inclusion criteria (ie. “healthy T2D”) and the 
fact that T2D is typically characterized as adult onset, this was expected. However, the 
incidence of T2D is increasing in a younger population and older T2D usually present 
with more complications. The applicability of this exercise intervention needs to be tested 
in additional age groups, but it is likely that exercise will be beneficial to all those able to 
perform it.  
 
42 
 
 One of the difficulties with self reports for physical activity and diet is that they 
will undoubtedly contain some error (incorrect recall, incorrect understanding of 
questions, need to appease experimental testers etc.).  However, the tests we have 
employed to monitor diet and physical activity have been validated and proven reliable in 
large populations.  Future studies could include devices such as pedometers and 
biometric readers in order to better assess ones activity level and diet.  However, this too 
has its downfalls as individuals may take off or improperly place these items (such as a 
pedometer) at certain points (e.g. for comfort). As a result, the most accurate 
determination of physical activity and if one increased/decreased their levels is to do an 
actual fitness test where O2 and CO2 levels were determined at voluntary exhaustion to 
determine their actual VO2max. A VO2maxtest with expired gas collection may provide 
more accuracy and consequently be able to detect smaller changes in these measures.  It 
should be noted, however, that this type of test is rather difficult for a new exerciser, 
especially one who is diabetic.  Moreover, compliance is important in implementing any 
training regimen, therefore, performing exercise that requires a specialized bike, 
equipment, and is very demanding is not a practical model for a diseased and unfit 
population.  
In terms of initial VO2maxtesting, VO2 between the first and second test may have 
been compromised because we did not allow a day for participants to become 
familiarized with the cycle ergometer. This may have influenced our results as the 
participants knew what to expect for the second test and were more accustomed, efficient 
or relaxed during the cycle ergometer testing procedures. Since the submaximal tests is 
based on HR, a lower HR because of these or any other factors may have impacted the 
findings. Future studies should include a separate day of familiarization with the cycle 
ergometer to combat this potential confounding variable or utilize the more direct 
measure of expired gases as noted above.  
Eleven participants completed this study, but only nine had measureable plasma 
insulin levels and were therefore able to be included in our analyses. . However, given the 
fact that a small to medium effect size  (eta2=0.15) was observed for changes in HOMA-
IR, the inclusion of a greater amount of participants to obtain a power level of at least 
0.35 would allow a better analysis of the effects of our exercise intervention. 
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Nonetheless, small effect sizes are important and are a proof of a concept that can be 
repeated.  We observed several interesting trends in this study and it is important to note 
that weak relationships may be just as important to health, health policy and public health 
awareness.  As noted in the discussion, a small change in HOMA (~1 point) results in a 
significant reduction in CVD risk.  With this knowledge, people can still change their 
habits and way of life based on information obtained in the present study.  
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Appendix F  
 
Additional Participants Data. Includes all 11 participants.  Participants are identified by number 
and sex only.  ND represents not detectable, and NA represents not available.  
  
Serum Insulin (uU/mL) 
    
ID T0 T1 T2 
1-F 55.16 47.658 42.696 
2-M 19.94 17.53 19.003 
3-F 9.267 16.884 20.891 
4-F ND ND ND 
5-M 17.89 18.083 13.246 
6-F 16.165 25.062 10.199 
7-F 61.124 34.967 15.618 
8-M 31.619 32.299 22.131 
9-F 28.891 22.898 12.21 
10-F ND ND ND 
11-F 24.492 33.947 43.488 
    
Mean 29.4 27.7 22.2 
SD 17.7 10.3 12.5 
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Plasma Glucose (mmol/L) 
    
ID T0 T1 T2 
1-F 8.2 8.7 7.7 
2-M 10.4 9.75 11.35 
3-F 8.5 10 14.55 
4-F 5.8 4.45 4 
5-M 8.25 7.95 6.75 
6-F 7.65 7.85 6.35 
7-F 6.95 6.4 5.7 
8-M 15.65 15.65 14.6 
9-F 6.25 6.1 5.9 
10-F 4.55 25 9.6 
11-F 6.7 5.8 6.75 
    
Mean 8.1 9.8 8.5 
SD 3.0 5.9 3.6 
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HOMA-IR (%) 
    
ID T0 T1 T2 
1-F 7.4 6.5 5.7 
2-M 3 2.6 2.9 
3-F 1.4 2.5 3.6 
4-F NA NA NA 
5-M 2.6 2.6 1.8 
6-F 2.3 3.5 1.4 
7-F 7.4 4.6 2.1 
8-M 5.8 5.9 3.8 
9-F 3.8 3 1.6 
10-F NA NA NA 
11-F 3.3 4.4 5.7 
    
Mean 4.1 4.0 3.2 
SD 2.2 1.5 1.7 
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%S (insulin sensitivity) 
    
ID T0 T1 T2 
1-F 13.6 15.3 17.4 
2-M 33.6 38.6 34.5 
3-F 73.9 39.8 27.7 
4-F NA NA NA 
5-M 39.1 39 54.7 
6-F 43.8 28.6 71.6 
7-F 13.5 21.8 48.4 
8-M 17.2 16.9 26.1 
9-F 26.3 32.9 61 
10-F NA NA NA 
11-F 30.2 22.9 17.6 
    
Mean 32.4 28.4 39.9 
SD 19.0 9.6 19.7 
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%B (beta cell function) 
    
ID T0 T1 T2 
1-F 155 126.1 141.5 
2-M 47.6 48.1 39.6 
3-F 38.4 44.7 29.2 
4-F NA NA NA 
5-M 65.6 70.7 76.8 
6-F 70 92 72 
7-F 209.4 168.9 119.2 
8-M 38.6 39.3 30.5 
9-F 153.9 136.7 94 
10-F NA NA NA 
11-F 120.5 197.9 179.7 
    
Mean 99.9 102.7 86.9 
SD 62.0 57.7 52.2 
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Blood Glucose (mmol/L) 
  Test 1 Test 2 Test 3  Test 4 Test 5 Test 6 
ID Pre Post  Pre Post Pre Post  Pre Post  Pre Post Pre Post  
1 9.6 8.1 7.6 5.6 5.6 3.6 6.4 5.3 7.9 7.3 5.9 5.9 
2 5 6.1 6.2 5.2 9.7 8.3 7.6 7 11.4 8.9 8.9 7.6 
3 10.8 13.5 10.2 10.4 13.1 12.6 10.6 10.7 11 10.3 15.9 16.2 
4 21.8 15.8 15.1 8.9 19.6 17.8 14.6 13.6 15.9 12.8 18.4 15.8 
5 9.6 6.4 7.4 6.7 9.2 6.8 8.9 8.1 7.9 7.2 12.6 9.1 
6 5.1 4.8 7.6 6.5 7.7 7.2 7.4 6.9 6.4 5.2 7.1 6.1 
7 12.2 10.4 4.4 4.2 7.4 5.9 6.3 4.6 7.2 6.1 4.8 5.3 
8 13.1 11.8 15.2 12.3 9.9 7.5 20.3 15.3 8.9 7.6 12.6 11.3 
9 5.8 5.4 5.3 5.1 5.7 5.4 8.6 5.7 5.4 6.1 6.3 5.3 
10 5.7 4.9 11.7 8 12.6 10 12.8 14.7 9.6 7.6 9.1 6.7 
11 9.6 7.1 7.6 6.8 7.8 5.3 10.4 6.8 8.8 7.1 6.5 5.7 
             
Mean 10.3 9.1 8.8 7.2 9.8 8.3 10.1 8.6 9.1 7.9 10.3 9.2 
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Heart Rate Responses to each HIIT bout indicated in beats per minute (bpm) and then as a 
percent of predicted maximum heart rate (220‐age). 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